Gene therapy for cancer halted after patient death – BioNews
|
Gene therapy for cancer halted after patient death
BioNews Two trials assessing gene therapy for blood cancer have been put on hold by the US Food and Drug Administration (FDA), following a patient fatality. The therapy, known as 'off-the-shelf' CAR-T immunotherapy, used genetically modified immune system T … |
